A UK start-up, Procyon Diagnostics, has spun out of Queen Mary University of London with a mission to deliver tests that can spot cancer in the early stages, when treatment has the best chance of ...
Results from the PATHFINDER 2 trial of Grail's blood test for multiple cancers have shown greater efficacy and a lower rate of false alarms than in an earlier trial of the technology. The Galleri ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback